CIRA Affiliated Project
P.I.
on Subcontract: |
 |
|
P.D.: |
 |
|
Grant Type: |
 |
Research |
Funder: |
 |
National Institute on Drug Abuse |
Geographic Region(s): |
 |
U.S. - Outside of CT. |
Type of Research:
|
 |
Vulnerable Populations:
Drug Users
|
| Back to Top |
 |
 |
 |

PI on parent grant: Douglas K. Owens, Stanford University
This research is motivated by the recent report of the Institute of Medicine's Committee on HIV Prevention Strategy in the United States, which advocates the use of evaluation and cost-effectiveness frameworks for resource allocation decisions. The project aims to promote reasoned policy making in the realm of AIDS and drug abuse prevention via the development of mathematical and economic models. To achieve this goal, the project has the following specific aims:
- To construct "production functions" that characterize the relationship between money spend to modify risky behaviors and empirically observed changes in those behaviors.
- To develop model-based methods of translating the behavioral impact of HIV-related interventions into epidemiologically meaningful outcome measures.
- To assign appropriate outcome measures such as economic cost, public health impact, and cost-effectiveness to models of HIV intervention programs.
- To assess the impact and cost-effectiveness of particular interventions aimed at slowing the spread of HIV and drug abuse, including harm reduction, syringe exchange, drug abuse treatment, programs aimed at reducing the prevalence and incidence of sexually transmitted diseases, and HIV counseling, testing and referral.
- To guide prevention strategy and the allocation of societal resources by examining the impact and cost-effectiveness of portfolios of interventions. This includes assessing the appropriateness of epidemiologically targeted versus blanketed HIV prevention programs, as well as analyzing other national and international HIV prevention strategies.
- To examine the relationship between policy modeling and public health decision making in the areas of AIDS and substance abuse.
|
| Back to Top |

Not Available
|
| |
|
2006
Walensky, R.P., Paltiel, A.D., Losina, E., Mercincavage, L.M., Schackman, B.R., Sax, P.E., Weinstein, M.C., and Freedberg, K.A.
(2006).
The Survival Benefits of AIDS Treatment in the United States.
Journal of Infectious Diseases, 194(1), 11-19.
|
| Back to Top |
 |
|
 |
|
|
|
|
| CIRA eBULLETIN |
| Sign up to receive CIRA's weekly eBulletin. |
|
| YACS@CIRA |
Thursday, 12/03 12:30 PM - 1:30 PM

Speaker: Nabila El-Bassel, Columbia University

Title: HIV Among Drug Users in Kazakhstan: Driving Forces and Implications for HIV Prevention & Treatment

Location: CHIP, 2006 Hillside Rd Unit 1248, Storrs, CT

Video Conference: CIRA, Ste. 200, Rm. 202, 135 College St, New Haven, CT
|

 |
| WORLD AIDS DAY |
Tuesday, December 1 marks the 21st anniversary of World AIDS Day. All are welcome to attend a memorial service at the United Church on the Green in New Haven.

|
|